Your Sales Compensation Plan Was Built for a Commercial Model That No Longer Exists

The questioning is everywhere. 

In medical device, commercial leaders are reworking pay mix and quota structures to account for the shift from capital equipment cycles to service-and-utilization models. In pharma, they are adding outcomes-based measures to reflect value agreements that their legacy comp designs were never built to support. In diagnostics and health systems, they are trying to reconcile field force performance metrics with commercial contracts that have changed the definition of what a successful sale actually produces. 

The rethinking is appropriate. The level at which it is happening is not. 

Most HC/LS commercial organizations are redesigning plans. Very few are rebuilding architectures. And that distinction — between adjusting what sits on top and fixing what is underneath — is where the performance gap between leading and lagging organizations is generated, one planning cycle at a time. 

 

The Signal the Data is Sending 

The current state of HC/LS commercial performance is producing a pattern that should be difficult to dismiss. Sixty-seven percent of organizations in this sector are actively expanding their targeted incentive investment. In the same period, quota attainment is projected to decline 14 percent, and voluntary turnover among top commercial performers is trending upward — particularly in high-growth geographies and specialty categories — according to Alexander Group research tracking HC/LS commercial organizations. 

More spend. Less attainment. More departures among the people you most need to retain. 

A talent problem produces different data. Market conditions are genuinely complex in HC/LS — but complexity doesn't account for a pattern where incentive investment expands while attainment and retention both decline. That pattern has an architectural signature: an incentive system pushing more investment through a structure increasingly misaligned with the commercial reality it was designed to govern. 

When investment and outcome move in opposite directions, the conversation about what to change has to move upstream. 

 

What Plan Redesign Cannot Fix 

Three diagnostic signals distinguish a plan design problem from an architecture problem. If your organization is experiencing any of them, a new plan will not resolve it. 

Quota mistrust that survives redesign. When sellers consistently question whether their quota reflects what their territory can realistically produce — not as a negotiating posture, but as a genuine operational concern — the source of the problem is the data and governance architecture behind the quota-setting process, not the number itself. Xactly's research shows only 25 percent of sellers understand how their quota was derived. In HC/LS commercial environments, where territory performance is constrained by payor mix, account access realities, and market access conditions that shift faster than annual planning cycles can track, that number carries particular weight. Sellers who cannot evaluate whether their target is commercially rational cannot commit fully to that target — and adjusting the number doesn't close the evidence deficit underneath it. 

Attainment distributions that don't respond to plan changes. Every HC/LS commercial organization has run this experiment: a new plan launches, the distribution looks similar to the previous year's, and post-mortems attribute it to market conditions or product launch timing. Before accepting that explanation, examine whether the plan change actually altered what drives attainment distribution — territory balance, quota credibility, field force coverage against genuine market opportunity — or whether it adjusted surface features while leaving the structural drivers intact. A bimodal distribution that persists across multiple plan generations almost never originates in plan design. What looks like a performance problem is almost always a territory and quota architecture problem expressing itself in attainment data. 

Shadow accounting that doesn't disappear post-implementation. When sellers systematically track their own compensation in parallel to the official calculation, they are communicating something precise: the architecture cannot be trusted enough to stake behavior on. Adding reporting features or increasing payout transparency doesn't change that — not if the underlying crediting logic, the territory assignment process, or the quota derivation methodology cannot be explained in terms sellers recognize as connected to their actual commercial environment. Trust is a design property. It cannot be retrofitted through communication. 

 

The Question that Changes what Becomes Possible 

Most HC/LS commercial organizations evaluate their compensation programs against the wrong benchmark — asking whether the plan produced acceptable attainment, manageable dispute volumes, and competitive total compensation. Operational questions, generating operational answers. 

The architectural question is different: does your current SPM infrastructure produce the specific commercial behaviors your go-to-market strategy requires — and do you have the performance intelligence to know whether it is doing that? 

That question reframes the entire diagnostic. Disputes point to crediting logic and plan transparency failures, not calculation errors. Attainment clustering points to quota validity and territory design failures, not talent distribution. Shadow accounting points to an architecture that cannot be trusted — not a communication gap that better reporting will close. 

All three signals are pointing at the same place. Addressing them one at a time, at the plan level, produces three consecutive redesigns with the same distribution. Addressing the architecture they are pointing to is the move that changes the outcome. 

Your plan may be calculating correctly. Correct calculation and genuine commercial performance are not the same thing. 

 

Where the Architecture Conversation Starts 

Argano's Sales Performance Management practice is built around exactly this transition — from technically functional comp administration to the operating model and data architecture that makes incentive investment produce the commercial performance it is designed to produce. 

The entry point is a structured SPM Assessment: a diagnostic of compensation design, territory and quota architecture, data infrastructure, and platform utilization — benchmarked against what leading HC/LS commercial organizations have already built. It surfaces what the plan-level evidence has been pointing to, andproduces a prioritized roadmap for organizations ready to move from symptom management to architecture.